Protocolo de evaluación de la afectación hepática en las enfermedades inmunológicas
- González Olivares, C. 1
- Albillos Martínez, A. 1
- 1 Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España
ISSN: 0304-5412
Argitalpen urtea: 2020
Zenbakien izenburua: Enfermedades del aparato digestivo (V)Enfermedades hepáticas. Hepatitis
Saila: 13
Zenbakia: 5
Orrialdeak: 277-281
Mota: Artikulua
Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado
Laburpena
In the following protocol we will discuss the diagnostic orientation of a patient with immune disease and liver involvement. It is not unusual for the liver to be affected in the context of systemic and autoimmune diseases. Although in most cases they will be biochemical alterations without clinical relevance, in some cases liver damage may occur leading to the development of cirrhosis or acute liver failure. In a patient with an autoimmune disease that presents with liver disease we should always consider the possibility of having a primary liver disease. Similarly we must rule out drug hepatotoxicity. We present the main damage patterns associated with immunological diseases that can help guide the diagnosis of these patients.
Erreferentzia bibliografikoak
- Averbukh LD, Wu GY. Role of biologics in the development of autoimmune hepatitis: a review. J Clin Transl Hepatol. 2018;6(4):402-9
- García-Samaniego J, Berenguer Haym M. Enfermedades hepáticas de base autoinmune. Madrid: Imaidea; 2015.
- Hodgson HJF. The liver in systemic disease. En: Sheila Sherlock, editor. Diseases of the liver and the biliary system. 12ª ed. UK: Blackwell Publishing; 2011. p. 615-31.
- Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepa-titis. Hepatology. 2010;51(6):2193-213.
- Takahashi A, Abe K, Saito R, Iwadate H, Okai K, Katsushima F, et al. Liver dysfunction in patients with systemic lupus erythemato-sus. Intern Med. 2013;52:1461-5